Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Post by DrHolidayon Oct 01, 2018 2:34pm
164 Views
Post# 28723396

Price volatility ICO on sale!

Price volatility ICO on sale!Thank you for your candor regarding your sale today. I think you've nailed the bottom on the chart here, and the opportunity to buy back lower is rather unlikely although it could work if other shareholders decide to abandon ship, but the bounce off the low will have to be confirmed along with the stock trading back up above the 10 cent level. Capitulation often marks a low and smart money has been known to buy on such weakness, but it is only smart money if the buyer is right about factors which could turnaround the company and regain traction to the upside.
The catalyst or news event that we`ve all been waiting for is now overdue, and frankly I believe that we are right on the cusp of a major mutually beneficial JV deal to fund Oral B Amphotericin right through phase II and phase III human trials.

It is never a good idea to throw the baby out with the bathwater.
Patience is a virtue and will be rewarded. If someone bought at higher prices, then all this is just an opportunity to bring your average cost down and add to your position. The timing is right in my opinion, and when to buy is sometimes as important as what to buy. So, the ``what`` is ICO, and the ``when`` is now. Good Luck and Happy Trails to you.

DOC.
<< Previous
Bullboard Posts
Next >>